glp 1 agonist stands for Glucagon-like peptide-1 Comparing Ozempic, Wegovy and Other
Description
TBR News Media
As this medication is newer, we continue to closely monitor the research and patient outcomes
Earlier versions of GLP-1 drugs, such as exenatide (Byetta), increased the risk for pancreatic cancer or certain types of thyroid cancer and even instances of autoimmunity
Future Potential : The robust pipeline of increasingly effective agents, combined with emerging oral formulations and potential cost reduction strategies, suggests that current limitations may be surmountable with continued innovation and policy development
In: Katzung's Basic & Clinical Pharmacology
GLP-1 receptor agonists augment glucose-dependent insulin release and reduce glucagon secretion and gastric emptying while inhibiting food intake and reducing body weight
